Unresponsiveness to Glucose in a Streptozocin Model of Diabetes: Inappropriate Insulin and Glucagon Responses to a Reduction of Glucose Concentration

The neonatal streptozocin (STZ) rat model of NIDDM has been previously found to have a markedly reduced insulin response to an acute increase in glucose concentration. We studied the effect of an acute reduction in glucose concentration on insulin and glucagon secretion in this model and contrasted the results with the effects of epinephrine and somatostatin using the in vitro isolated, perfused pancreas. The reduction in perfusate glucose concentration from 11.1 to 2.8 mM caused a rapid suppression of insulin release in the control rats, but had no inhibitory effect in the STZ group. Epinephrine (55 nM) and somatostatin (110 nM) caused similar decreases in insulin secretion in both groups. The glucose reduction also caused an increase in glucagon release in the controls, but had no effect in the STZ rats. Epinephrine, however, stimulated glucagon secretion in both groups in a similar fashion, and inhibition by somatostatin was also comparable. The baseline insulin and glucagon concentrations were enhanced in a separate series of experiments by the addition of arginine (5 mM) to the perfusate, and while the insulin and glucagon responses to the glucose reduction remained lost, appropriate inhibition of insulin secretion was demonstrated in the STZ rats with epinephrine. These data indicate that A- and B-cells in this rat model of NIDDM are selectively unresponsive to both increases and decreases in glucose concentration, while the responsiveness to nonglucose agents remains intact.

[1]  J. Leahy,et al.  Abnormal Glucose Regulation of Insulin Secretion in Models of Reduced B-Cell Mass , 1984, Diabetes.

[2]  P. Cryer,et al.  Defective glucose counterregulation after subcutaneous insulin in noninsulin-dependent diabetes mellitus. Paradoxical suppression of glucose utilization and lack of compensatory increase in glucose production, roles of insulin resistance, abnormal neuroendocrine responses, and islet paracrine intera , 1984, The Journal of clinical investigation.

[3]  S. Bonner-Weir,et al.  Abnormal Islet and Adipocyte Function in Young B-cell-deficient Rats with Near-Normoglycemia , 1984, Diabetes.

[4]  R. Unger.  Insulin-Glucagon Relationships in the Defense Against Hypoglycemia , 1983, Diabetes.

[5]  S. Bonner-Weir,et al.  Partial pancreatectomy in the rat and subsequent defect in glucose-induced insulin release. , 1983, The Journal of clinical investigation.

[6]  S. Bonner-Weir,et al.  Islet Secretion in a New Experimental Model for Non-insulin-dependent Diabetes , 1981, Diabetes.

[7]  S. Bonner-Weir,et al.  Responses of Neonatal Rat Islets to Streptozotocin: Limited B-Cell Regeneration and Hyperglycemia , 1981, Diabetes.

[8]  J. Halter,et al.  Mechanisms of impaired acute insulin release in adult onset diabetes: studies with isoproterenol and secretin. , 1978, The Journal of clinical endocrinology and metabolism.

[9]  P. Lacy,et al.  Somatostatin inhibition of glucose-induced electrical activity in cultured rat islet cells. , 1977, The American journal of physiology.

[10]  G. Weir,et al.  Glucagon Secretion from the Perfused Pancreas of Streptozotocin-treated Rats , 1976, Diabetes.

[11]  M. Kikuchi,et al.  An effect of hyposmolarity on insulin release in vitro. , 1975, The American journal of physiology.

[12]  G. Grodsky,et al.  Characterization of the effects of arginine and glucose on glucagon and insulin release from the perfused rat pancreas. , 1974, The Journal of clinical investigation.

[13]  M. Williams,et al.  A simple and inexpensive membrane "lung" for small organ perfusion. , 1974, Journal of lipid research.

[14]  S. D. Knowlton,et al.  Glucagon Secretion from the Perfused Rat Pancreas , 1974 .

[15]  R. Turner,et al.  A sensitive, precise radioimmunoassay of serum insulin relying on charcoal separation of bound and free hormone moieties. , 1972, Acta endocrinologica.

[16]  D. Porte,et al.  Acute and steady-state insulin responses to glucose in nonobese diabetic subjects. , 1972, The Journal of clinical investigation.

[17]  R. Landgraf,et al.  Kinetics of insulin release from the perfused rat pancreas caused by glucose, glucosamine, and galactose. , 1971, Proceedings of the National Academy of Sciences of the United States of America.

[18]  W. A. Müller,et al.  Studies of pancreatic alpha cell function in normal and diabetic subjects. , 1970, The Journal of clinical investigation.

[19]  G. Grodsky,et al.  Early Phase of Insulin Release , 1968, Diabetes.

[20]  T. Deckert.  Insulin secretion following administration of secretin in patients with diabetes mellitus. , 1968, Acta endocrinologica.

[21]  G. Grodsky,et al.  Dynamics of insulin secretion by the perfused rat pancreas. , 1968, Endocrinology.

[22]  W. Malaisse,et al.  Effects of adrenergic and cholinergic agents upon insulin secretion in vitro. , 1967, Endocrinology.

[23]  G. Grodsky,et al.  Effect of pulse administration of glucose or glucagon on insulin secretion in vitro. , 1967, Metabolism: clinical and experimental.